Aiforia Technologies Plc, Press Release, December 17, 2025 at 9:00 a.m. EET
Aiforia Technologies Plc announces the expansion of its AI technology platform featuring the Vision Transformer architecture. Leveraging patent-pending innovation, Aiforia’s new Foundation Engine overcomes the common hurdles faced with foundation models. It delivers rapid execution and cost-efficient processing for both AI training and image analysis, while still benefiting from the large, diverse datasets inherent to foundation models. With this launch, Aiforia not only adopts the Vision Transformer technology into its own product development but also makes it available to users of its unique AI training tool, Aiforia® Create.
Aiforia’s Foundation Engine leverages foundation models, pre-trained on vast image datasets, and combines them with task-specific annotations provided by pathologists. This optimized combination significantly accelerates AI model development, resulting in robust models that generalize effectively across diverse environments. AI models built with Aiforia’s Foundation Engine maintain the high level of transparency of previous generations, offering visual, pixel-level analysis and quantitative data alongside sample scoring based on the AI-generated results.
“Harnessing this next-generation AI technology provides us with a significant competitive edge by accelerating our clinical AI model development and enhancing the robustness of our AI models. These enhancements are now also integrated into Aiforia® Create, our distinct AI training tool, which provides pathologists and scientists with an unparalleled environment for developing their own AI models for diverse image analysis applications”, says Jukka Tapaninen, CEO of Aiforia.
Further inquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology.
Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France, and maintains a network of local representatives across Europe and North America. Aiforia’s diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient.
Find out more at www.aiforia.com
Back to all blog posts
